UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040648
Receipt number R000042909
Scientific Title Clinical Effectiveness of Screening Sheet to Standardize Cardiac Resynchronization Therapy in Heart Failure Patients
Date of disclosure of the study information 2020/06/05
Last modified on 2023/12/08 18:34:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Effectiveness of Screening Sheet to Standardize Cardiac Resynchronization Therapy in Heart Failure Patients

Acronym

Clinical Effectiveness of Screening Sheet to Standardize Cardiac Resynchronization Therapy in Heart Failure Patients

Scientific Title

Clinical Effectiveness of Screening Sheet to Standardize Cardiac Resynchronization Therapy in Heart Failure Patients

Scientific Title:Acronym

Clinical Effectiveness of Screening Sheet to Standardize Cardiac Resynchronization Therapy in Heart Failure Patients

Region

Japan


Condition

Condition

Heart Failure Patients

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The study considers CRT treatment as one of the standard treatments for heart failure treatment, and what standard heart failure treatments are available for heart failure patients with systolic dysfunction, including those in NYHA second-degree outpatient visits. The purpose of this study was to create a flow sheet and screen for whether or not heart failure patients with symptoms of NYHA of 2 degrees or more can confirm the rate of intraventricular conduction disorder and CRT treatment can be used as a standardized heart failure treatment .

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

We consider CRT treatment as one of the treatments that should be established as a standard treatment for heart failure treatment, and what kind of standard heart failure treatment is given to patients with heart failure who have systolic dysfunction before CRT treatment.

Key secondary outcomes

We check the rate at which heart failure patients with systolic failure have intraventricular conduction disturbances, we use a flow sheet to screen whether CRT treatment can be used as a standardized heart failure treatment.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

The subjects are those who have undergone CRT and those who are considering CRT treatment.

Key exclusion criteria

None.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Takano

Organization

St. Marianna university

Division name

Division of Cardiology

Zip code

216-8511

Address

2-16-1, Sugao, Miyamae-Ku, Kawasaki city, Kanagawa

TEL

044-977-8111

Email

takano.makoto@marianna-u.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Takano

Organization

St. Marianna university

Division name

Division of Cardiology

Zip code

216-8511

Address

2-16-1, Sugao, Miyamae-Ku, Kawasaki city, Kanagawa

TEL

044-977-8111

Homepage URL


Email

takano.makoto@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna university

Institute

Department

Personal name



Funding Source

Organization

Medtronic

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna university

Address

2-16-1, Sugao, Miyamae-Ku, Kawasaki city, Kanagawa

Tel

044-977-8111

Email

takano.makoto@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2019 Year 02 Month 26 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 12 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, we consider ventricular resynchronization therapy (CRT therapy) as one of the treatments that should be established as the standard treatment for heart failure treatment, and how to treat heart failure patients with systolic insufficiency, including patients undergoing NYHA 2 outpatient visit. Standard heart failure treatment is performed, and heart failure patients with NYHA2 or higher confirm the rate of intraventricular conduction disorder and prepare a flow sheet to screen whether CRT treatment can be used as a standardized heart failure treatment and screening.


Management information

Registered date

2020 Year 06 Month 04 Day

Last modified on

2023 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042909


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name